Like multiple myeloma, MGUS starts in a type of white blood cell called plasma cells. These cells make m-protein. This abnormal protein can build up in your blood and urine. Blood and urine tests can ...

Get Instant Summarized Text (Gist) Blocking the chemokine receptor CCR1 can enhance the response of multiple myeloma cells to dexamethasone, a common treatment. High CCR1 levels are associated ...

Multiple myeloma is part of the spectrum of diseases ... cell clone and subsequent overabundance of monoclonal paraprotein (M protein). [13] ...

This depends on: The number of myeloma cells in the body. Bone damage caused due to the cells. M-protein levels in blood and urine. Blood calcium levels Hb and Albumin levels. The kidney damage ...

Talquetamab (Talvey) is another bispecific antibody that attaches to GPRC5D protein on myeloma cells and some other cells. Although targeted therapies have fewer side effects than older cancer ...

Multiple myeloma is a rare blood cancer of the plasma cells in bone marrow -- the soft, spongy interior of bone where all ...

Researchers at the VIB-UGent Center for Medical Biotechnology have discovered a promising strategy to improve treatment responses in multiple myeloma patients by blocking a protein that plays a key ...

Scientists at Sun Yat-Sen University and affiliated organizations investigated the role of OGT in the progression and drug resistance of multiple myeloma.

A 59-year-old woman presented to the emergency department with a left rib fracture and was diagnosed with IgA multiple myeloma ... Investigations. Serum protein electrophoresis, contrast CT ...